Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

More News From sports.morningdispatcher.com

World champion Hamilton wins season-ending Abu Dhabi GP

Dec 11, 2018

ABU DHABI, United Arab Emirates — World champion Lewis Hamilton coasted to victory from pole position at the season-ending Abu Dhabi Grand Prix on Sunday. Having already secured a fifth F1 title, the British Mercedes driver beat Ferrari's Sebastian Vettel at the Yas Marina circuit to secure his 11th win of the season and 73rd of his career. It was a symbolic finish to a season where, again, he showed his superiority under pressure to beat Vettel into second place overall for the second straight year. Red Bull driver Max Verstappen finished third ahead of teammate Daniel Ricciardo for a...

Recovering Lauda hopes to be back working with Mercedes soon

Dec 11, 2018

ABU DHABI, United Arab Emirates — Niki Lauda hopes to be back working with Mercedes soon as he continues his recovery from a lung transplant. The three-time Formula One champion appeared cheerful as he posted a message on the Mercedes team's Twitter account on Saturday. Speaking softly but clearly, Lauda says "the important message is I will be there soon" before thanking all his fans for the "unbelievable" support he has received. The 69-year-old Lauda, who received a new lung on Aug. 2, is non-executive chairman of Mercedes. He has had a close working relationship with five-time F1 champion Lewis...

England fights back against Sri Lanka to reach 259-6 at tea

Dec 11, 2018

KANDY, Sri Lanka — England fought back against Sri Lanka on Friday to reach 259-6 at tea on the third day of the second test, leading by 213 runs with four wickets in hand. England captain Joe Root, who is nearing his 15th test hundred, was unbeaten on 98 with Ben Foakes on 19 at the Pallekele International Stadium. At lunch, England was badly placed at 131-4, leading only by 85 runs. But the tourists took back control while losing only two wickets in the next session. Root and Jos Buttler added 74 runs for the fifth wicket. Buttler was...

Molinari 1 shot ahead of Fleetwood in race for European No 1

Dec 11, 2018

DUBAI, United Arab Emirates — Francesco Molinari missed two par putts from less than two feet in his opening round of the World Tour Championship on Thursday to give Tommy Fleetwood a sliver of a chance of keeping the European Tour season title. Molinari was cruising at one stage, having reached 6-under par after 14 holes, but three-putted the 15th and 18th holes to finish on 4-under 68 at Jumeirah Golf Estates. Fleetwood, his only remaining rival in the Race to Dubai, completed his bogey-free round with a wonderful 25-foot birdie putt from off the green on the par-5 18th,...

Silva pushes Sri Lanka to lead over England in 2nd test

Dec 11, 2018

KANDY, Sri Lanka — Sri Lanka fought back admirably against England thanks to a back-to-the-wall 85 by Roshen Silva to earn a first-innings lead of 46 runs in the second test on Thursday. However, Silva's failure to ground his bat and run short conceded a rare five penalty runs to England. Sri Lanka was all out for 336 in reply to England's 285, boosted to 290 with the penalty runs at Pallekele International Stadium. England faced just one over before stumps on day two and promoted Jack Leach to open the innings. The nightwatchman negotiated six deliveries from Dilruwan Perera...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress